Skip to main content
. 2021 Jul 29;40(17):e108588. doi: 10.15252/embj.2021108588

Figure 4. SARS‐CoV‐2 convalescents make potently neutralizing N antibodies whose activity correlates with the number of active N‐specific T cells.

Figure 4

  • A
    Capillary‐based protein detection (Jess) of N antibodies in convalescent sera, quantified by chemiluminescence.
  • B
    Quantification of SARS‐CoV‐2 intracellular neutralization by electroporated convalescent sera using EDNA and RT–qPCR (as % of PBS condition).
  • C
    Correlation between N‐antibody titre, as calculated by Jess, and intracellular neutralization (fold decrease in SARS‐CoV‐2 replication), as measured by EDNA, in convalescent sera from multiple individuals.
  • D
    Intracellular neutralization of SARS‐CoV‐2 by titrated serum from two strongly N antibody‐positive individuals.
  • E
    ELISpot measuring IFNγ production in T cells from SARS‐CoV‐2 convalescents upon stimulation with a peptide library covering N‐protein.
  • F
    Correlation between N‐specific T‐cell activity and intracellular neutralization activity.
  • G
    Correlation between N‐specific T‐cell activity and N‐antibody titre.

Data information: All data represent at least three independent replicates. Error bars depict the mean ± SEM. Statistical analysis was performed using a semilog non‐linear fit (F, G).